Aigen Investment Management, LP Teva Pharmaceutical Industries LTD Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $315,309 - $414,719	43,793 New	43,793 $329,000
Q3 2022 Nov 09, 2022	BUY	$6.86 - $11.95 $1.42 Million - $2.47 Million	206,743 New	206,743 $1.67 Million
Q1 2022 May 05, 2022	SELL	$7.33 - $9.39 $397,601 - $509,341	-54,243 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.9 - $10.19 $428,519 - $552,736	54,243 New	54,243 $449,000
Q2 2021 Aug 10, 2021	SELL	$9.9 - $11.56 $133,244 - $155,586	-13,459 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$10.34 - $12.81 $139,166 - $172,409	13,459 New	13,459 $155,000
Q1 2020 May 08, 2020	SELL	$6.69 - $13.45 $390,582 - $785,251	-58,383 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$6.53 - $10.72 $381,240 - $625,865	58,383 New	58,383 $572,000

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.